The paradox of decreasing nonmedical opioid analgesic use and increasing abuse or dependence — An assessment of demographic and substance use trends, United States, 2003–2014

Addictive Behaviors

Volumn 65, Issue , 2017, Pages 229-235

  Jones, Christopher M ^a  

^a U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

Author keywords

Nonmedical use; Opioid abuse; Opioid addiction; Overdose; Substance abuse; Substance use

Indexed keywords

CANNABIS; COCAINE; DIAMORPHINE; NALOXONE; OPIATE; SEDATIVE AGENT; TRANQUILIZER; NARCOTIC ANALGESIC AGENT;

ADOLESCENT; ADULT; ALCOHOL CONSUMPTION; ALCOHOLISM; ANALGESIC AGENT ABUSE; ARTICLE; CANNABIS USE; CHILD; FEMALE; GROUPS BY AGE; HOUSEHOLD INCOME; HUMAN; INAPPROPRIATE PRESCRIBING; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICALLY UNINSURED; OPIATE ADDICTION; UNITED STATES; AGE DISTRIBUTION; HEALTH SURVEY; PRESCRIPTION DRUG MISUSE; SEX RATIO; SOCIOECONOMICS; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANALGESICS, OPIOID; CHILD; FEMALE; HEALTH SURVEYS; HUMANS; MALE; OPIOID-RELATED DISORDERS; PRESCRIPTION DRUG MISUSE; SEX DISTRIBUTION; SOCIOECONOMIC FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84996629832     PISSN: 03064603     EISSN: 18736327     Source Type: Journal    
DOI: 10.1016/j.addbeh.2016.08.027     Document Type: Article

References (27)

1. American Psychiatric Association, The diagnostic and statistical manual of mental disorders. 4th ed., 1994, American Psychiatric Association, Washington, DC.
2. Becker, W.C., Fiellin, D.A., Merrill, J.O., Schulman, B., et al. Opioid use disorder in the United States: Insurance status and treatment access. Drug and Alcohol Dependence 94:1–3 (2008), 207–213.
3. Birnbaum, H.G., White, A.G., Schiller, M., Waldman, T., Cleveland, J.M., Roland, C.L., Societal costs of prescription opioid abuse, dependence, and misuse in the United States. Pain Medicine 12:4 (2011), 657–667.
4. Case, A., Deaton, A., Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century. Proceedings of the National Academy of Science 112:49 (2015), 15078–15083.
5. Centers for Disease Control and Prevention, Vital signs: Overdoses of prescription opioid pain relievers and other drugs among women – United States, 1999–2010. Morbidity and Mortality 62:26 (2013), 537–542.
6. Centers for Disease Control and Prevention, Wide-ranging online data for epidemiologic research (WONDER), multiple-cause-of-death file, 2014., 2016 (Available at:) http://wonder.cdc.gov.
7. Compton, W.M., Jones, C.M., Baldwin, G.T., Relationship between nonmedical prescription-opioid use and heroin use. New England Journal of Medicine 374:2 (2016), 154–163.
8. Conrad, C., Bradley, H.M., Broz, D., Buddha, S., Chapman, E.L., Galang, R.R., et al. Community outbreak of HIV infection linked to injection drug use of oxymorphone—Indiana, 2015. Morbidity and Mortality Weekly Report 64:16 (2015), 443–444.
9. Dart, R.C., Severtson, S.G., Bucher-Bartelson, B., Trends in opioid analgesic abuse and mortality in the United States. New England Journal of Medicine 372:16 (2015), 1573–1574.
10. Dowell, D., Haegerich, T.M., Chou, R., CDC guideline for prescribing opioids for chronic pain – United States, 2016. Morbidity and Mortality Weekly Report. Recommendations and Reports 65:1 (2016), 1–49.
11. Green, T.C., Grau, L.E., Carver, H.W., Kinzly, M., Heimer, R., Epidemiological trends and geographic patterns of fatal opioid intoxications in Connecticut, USA: 1997–2007. Drug and Alcohol Dependence 115:3 (2011), 221–228.
12. Han, B., Compton, W.M., Jones, C.M., Cai, R., Nonmedical prescription opioid use and use disorders among adults aged 18 through 64 years in the United States, 2003–2013. Journal of the American Medical Association 314:14 (2015), 1468–1478.
13. Hwang, C.S., Kang, E.M., Kornegay, C.J., Staffa, J.A., Jones, C.M., McAninch, J.K., Trends in the concomitant prescribing of opioids and benzodiazepines, 2002–2014. American Journal of Preventive Medicine S0749–3797:16 (2016), 00094–00095, 10.1016/j.amepre.2016.02.014 (pii).
14. Jones, C.M., Frequency of prescription pain relievers nonmedical use: 2002–2003 and 2009–2010. Archives of Internal Medicine 172:16 (2012), 1265–1267.
15. Jones, C.M., McAninch, J.K., Emergency department visits and overdose deaths from combined use of opioids and benzodiazepines. American Journal of Preventive Medicine 49:4 (2015), 493–501.
16. Jones, C.M., Mack, K.A., Paulozzi, L.J., Pharmaceutical overdose deaths, United States, 2010. Journal of the American Medical Association 309 (2013), 657–659.
17. Jones, C.M., Logan, J., Gladden, R.M., Bohm, M.K., Vital signs: Demographic and substance use trends among heroin users – United States, 2002–2013. Morbidity and Mortality Weekly Report 64:26 (2015), 719–725.
18. Paone, D., Dowell, D., Heller, D., Preventing misuse of prescription opioid drugs. City Health Information 30 (2011), 23–30.
19. Patrick, S.W., Davis, M.M., Lehmann, C.U., Cooper, W.O., Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012. Journal of Perinatology 35:8 (2015), 650–655.
20. Paulozzi, L.J., Jones, C.M., Mack, K.A., Rudd, R.A., Vital signs: Overdoses of prescription opioid pain relievers –United States, 1999–2008. Morbidity and Mortality Weekly Report 60:43 (2011), 1487–1492.
21. Rudd, R.A., Aleshire, N., Zibbell, J.E., Gladden, R.M., Increases in drug and opioid overdose deaths – United States, 2000–2014. Morbidity and Mortality Weekly Report 64:50–51 (2016), 1378–1382.
22. Substance Abuse and Mental Health Services Administration, Treatment episode data set (TEDS): 2003–2013. National Admissions to substance abuse treatment services. BHSIS series S-75, HHS publication no. (SMA) 15-4934. 2015, Substance Abuse and Mental Health Services Administration, Rockville, MD.
23. Substance Abuse and Mental Health Services Administration, 2014 national survey on drug use and health: Rockville, MD: United States Department of Health and Human Services. 2015, Substance Abuse and Mental Health Services Administration. Center for Behavioral Health Statistics and Quality.
24. U.S. Department of Health and Human Services, Opioid abuse in the U.S. and HHS actions to address opioid-drug related overdoses and deaths., 2015 (Available at:) https://aspe.hhs.gov/sites/default/files/pdf/107956/ib_OpioidInitiative.pdf.
25. Valdiserri, R., Khalsa, J., Dan, C., Holmberg, S., Zibbell, J., Holtzman, D., Compton, W., Confronting the emerging epidemic of HCV infection among young injection drug users. American Journal of Public Health 104:5 (2014), 816–821.
26. Warner, M., Chen, L.H., Makuc, D.M., Increase in fatal poisonings involving opioid analgesics in the United States, 1999–2006. 2009, CDC, National Center for Health Statistics, Hyattsville, MD (NCHS data brief no. 22).
27. Washington State Agency Medical Directors Group, Interagency guidelines on prescribing opioids for pain., 2015 (Available at:) http://www.agencymeddirectors.wa.gov/Files/2015AMDGOpioidGuideline.pdf.